BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12629110)

  • 21. Future directions: growth prediction models.
    Geffner ME; Dunger DB
    Horm Res; 2007; 68 Suppl 5():51-6. PubMed ID: 18174708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities.
    Wikland KA; Kriström B; Rosberg S; Svensson B; Nierop AF
    Pediatr Res; 2000 Oct; 48(4):475-84. PubMed ID: 11004238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
    Geffner M; Lundberg M; Koltowska-Häggström M; Abs R; Verhelst J; Erfurth EM; Kendall-Taylor P; Price DA; Jonsson P; Bakker B
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5435-40. PubMed ID: 15531494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
    Darendeliler F; Karagiannis G; Wilton P
    Horm Res; 2007; 68 Suppl 5():41-7. PubMed ID: 18174706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
    Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS.
    Boguszewski MC; Lindberg A; Wollmann HA
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2683-8. PubMed ID: 24758180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the response to growth hormone treatment in short children with chronic kidney disease.
    Mehls O; Lindberg A; Nissel R; Haffner D; Hokken-Koelega A; Ranke MB
    J Clin Endocrinol Metab; 2010 Feb; 95(2):686-92. PubMed ID: 20008024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.
    Ranke MB; Lindberg A; Martin DD; Bakker B; Wilton P; Albertsson-Wikland K; Cowell CT; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4748-53. PubMed ID: 14557450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O; Lindberg A;
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Japanese growth prediction model for prepubertal children with growth hormone deficiency.
    Seino Y; Yamashita S; Morisaki Y; Tanaka H; Chihara K; Tanaka T
    J Pediatr Endocrinol Metab; 2012; 25(9-10):909-15. PubMed ID: 23426820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two prediction models in a clinical setting to predict growth in prepubertal children on recombinant growth hormone.
    Ly HJ; Lindberg A; Fors H; Dahlgren J
    Growth Horm IGF Res; 2023 Feb; 68():101523. PubMed ID: 36669261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone treatment in short children born prematurely--data from KIGS.
    Boguszewski MC; Karlsson H; Wollmann HA; Wilton P; Dahlgren J
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1687-94. PubMed ID: 21430029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulant medication use and response to growth hormone therapy: an NCGS database analysis.
    Frindik JP; Morales A; Fowlkes J; Kemp S; Thrailkill K; Lippe B; Dana K
    Horm Res; 2009; 72(3):160-6. PubMed ID: 19729947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke MB; Lindberg A; Ferrández Longás A; Darendeliler F; Albertsson-Wikland K; Dunger D; Cutfield WS; Tauber M; Wilton P; Wollmann HA; Reiter EO;
    Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.